Effect Of Plasma Rich In Growth Factors In Knee Osteoarthritis
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
HYPOTHESIS:
The application of plasma rich in growth factors (PRGF) will improve the quality of life and
functional capacity of patients diagnosed with knee osteoarthritis, providing better
functional results than conventional treatment with viscosupplementation.
OPERATING ASSUMPTIONS
Following the initial administration of three doses of PRGF interspersed every 15 days,
applied via intraarticular, patients will present an improvement in functional test (WOMAC
and Lequesne scales) of 15% or more after 6 and 12 months compared to the control group with
patients treated with hyaluronic acid.
Phase:
Phase 3
Details
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias
Collaborator:
Funds for independent clinical research by the spanish ministry of health